Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001370146 | SCV001566612 | likely benign | Chuvash polycythemia; Von Hippel-Lindau syndrome | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004743439 | SCV005342147 | uncertain significance | VHL-related disorder | 2024-09-03 | no assertion criteria provided | clinical testing | The VHL c.398T>C variant is predicted to result in the amino acid substitution p.Phe133Ser. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. This variant has an interpretation of likely benign in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/1060684/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |